Showing results (2461-2470 of 2,927) with videos related to

Sort By:
Pageof 293
Cell Chemical Biology|October 7, 2022
Targeting telomerase reverse transcriptase with the covalent inhibitor NU-1 confers immunogenic radiation sensitizationYue Liu, Rick C Betori, Joanna Pagacz, et al.
Biochemistry|September 1, 2009
Hydrophobic photolabeling studies identify the lipid-protein interface of the 5-HT3A receptorMitesh Sanghvi, Ayman K Hamouda, Margaret I Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximabDesmond Curran, Jordi Giralt, Paul M Harari, et al.
Neurology|May 20, 1999
Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS)N C Sacktor, R H Lyles, R L Skolasky, et al.
Ejhaem|January 27, 2025
A novel TERT variant associated with a telomere biology disorder and challenges in variant classificationVahid Pazhakh, Lucy C Fox, Nicole Den Elzen, et al.
Journal of Neuroscience Methods|October 29, 2005
Synthesis, spectra, delivery and potentiometric responses of new styryl dyes with extended spectral rangesJoseph P Wuskell, David Boudreau, Mei-de Wei, et al.
Arthroscopy, Sports Medicine, and Rehabilitation|January 23, 2024
Patients With First-Time or Recurrent Patellar Dislocation Have a Similar High Rate and Extent of Articular Cartilage Injury Observed on Magnetic Resonance ImagingAndres R Perez, Carlo Coladonato, John Hayden Sonnier, et al.
Cancer|December 11, 2019
Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 studyJonathon B Cohen, Lai Wei, Kami J Maddocks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid TumorsLaura W Goff, Roger B Cohen, Jordan D Berlin, et al.
Gene Therapy|February 25, 2016
Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spreadT Shibata, H Uchida, T Shiroyama, et al.
Pageof 293